A panel of experts has deemed the digital rectal examination to be inferior to MRI in monitoring prostate cancer in men.
Academic rigour, journalistic flair
Articles on Prostate cancer
Displaying 1 - 20 of 67 articles
There have only been around 200 reported cases of foreign accent syndrome since it was first reported in 1907.
The miracles of modern medicine can be life-saving. Yet as Tim Baker writes, cancer patients yearn for a little empathy from their doctors, as well as scripts.
Due to increasing concerns over the health hazards posed by BPA, the Food and Drug Administration plans to reevaluate the safety of the controversial chemical for use in everyday products.
New research shows five bacteria are associated with an increased risk of aggressive prostate cancer.
Eating less meat was also linked with a lower risk of colorectal, breast, and prostate cancer.
More 9/11 responders died from physical and mental health issues after the terrorist attacks than on the day itself. And survivors are still suffering 20 years later.
Cancer mortality has dropped in the US, due largely to lower smoking rates, as well as early detection and better treatments. These advances often do not extend to people in developing nations.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Men with faults in their BRCA2 gene are at higher risk of aggressive prostate cancer.
A recent study reported a high consumption of dairy products was associated with an increased risk of prostate cancer. But breaking down the results shows there’s no reason for men to give up dairy.
Private proton centres are targeting patients who might not see the most benefit from expensive treatments.
A step-by- step coordinated physiotherapy plan is key for patients with disorders related to the pelvic floor.
The threshold for diagnosing common conditions such as high blood pressure, chronic kidney disease and gestational diabetes have all lowered in recent years. But for whose benefit?
Prostate cancer outcomes have differed between black men and other ethnic groups for decades. Could improving the way doctors talk and share information with black patients make a difference?
Labelling very low-risk conditions as cancers can cause unnecessary anxiety and lead to overtreatment.
Prostate cancer is the second deadliest cancer among men, but not all types of the disease are as deadly as others. That has led to confusion over screening. An expert explains why new guidelines make sense.
Historically the advice to cancer patients was to rest and avoid activity. We now know this advice may be harmful to patients, and that every person with cancer would benefit from exercise medicine.
Cancer doesn’t just grow uncontrollably. It has a smarter strategy than that.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
Top contributors
-
Head of Urology at Monash Medical Centre and Associate Professor of Surgery, Monash University
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Professor of Medicine, Bond University
-
Emeritus Professor in Public Health, University of Sydney
-
Assistant Professor, Bond University
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, The University of Western Australia
-
Professor of Public Health, Bond University
-
Senior Visiting Fellow, School of Medical Sciences, UNSW Sydney
-
Professor of Public Health, University of Sydney
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Associate Professor, Melbourne School of Population and Global Health, The University of Melbourne
-
Professor School of Public Health and Preventive Medicine, Monash University
-
Associate Professor, Bond University
-
Clinical Professorial Research Fellow, The University of Queensland
-
Associate Professor of Epidemiology, Deakin University
